IDIQ #75N93019D00031

Indefinite Delivery Contract for Infectious Agents Research Facility

This contract represents an indefinite delivery, indefinite quantity (IDIQ) agreement for the operation of a specialized facility focused on the study of infectious agents, vaccines, and antivirals in both adult and pediatric human subjects. The recipient of the contract is The Johns Hopkins University, a leading institution renowned for its extensive research capabilities in public health, particularly infectious diseases. The awarded contract is significant for advancing research and developing vaccines, thus playing a crucial role in public health challenges and response mechanisms. The scope of work encompasses managing clinical studies, ensuring regulatory compliance, data analysis, and providing necessary medical oversight within the facility. This contract was issued through a competitive bidding process resulting from a solicitation by the National Institutes of Health (NIH) targeting infectious diseases, showcasing the importance of rigorous scientific inquiry in this field. The operation period is part of a long-term agreement initiated in 2019, continuing to provide essential support for ongoing and future research initiatives. The original solicitation outlined comprehensive requirements for project management and operational efficiency, reflecting agencies' commitment to combating infectious diseases effectively.

Description

OPERATION OF A FACILITY FOR THE STUDY OF INFECTIOUS AGENTS, VACCINES AND ANTIVIRALS IN ADULT AND PEDIATRIC HUMAN SUBJECTS

View original record